The last 20 actions on file set price targets from $600.00 to $830.00, averaging $739.56.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 28 Sep 2026 | RBC Capital | BUY | $735.00 |
| 10 Sep 2026 | TD Cowen | BUY | $825.00 |
| 2 Sep 2026 | Argus Research | BUY | $600.00 |
| 2 Sep 2026 | Needham | BUY | $750.00 |
| 26 Aug 2026 | Barclays | BUY | $688.00 |
| 13 Aug 2026 | William Blair | BUY | – |
| 10 Aug 2026 | Goldman Sachs | BUY | $715.00 |
| 6 Aug 2026 | William Blair | BUY | – |
| 6 Aug 2026 | Craig-Hallum | BUY | $830.00 |
| 6 Aug 2026 | Piper Sandler | BUY | $732.00 |
| 6 Aug 2026 | Northland Securities | BUY | $800.00 |
| 6 Aug 2026 | Morgan Stanley | BUY | $640.00 |
| 6 Aug 2026 | Needham | BUY | $750.00 |
| 6 Aug 2026 | Goldman Sachs | BUY | $715.00 |
| 6 Aug 2026 | Barclays | BUY | $688.00 |
| 5 Aug 2026 | TD Cowen | BUY | $825.00 |
| 5 Aug 2026 | RBC Capital | BUY | $735.00 |
| 21 Jul 2026 | TD Cowen | BUY | $825.00 |
| 20 Jul 2026 | RBC Capital | BUY | $735.00 |
| 13 Jul 2026 | Piper Sandler | BUY | $724.00 |
No comments yet — be the first to weigh in on AXON.